← 產業報告目錄

Collagen & Gelatin Market by Source (Bovine, Porcine, Marine), Application (Orthopedic, Cardiovascular, Dental, Surgical), Competitive Landscape (Company Profile, Market share, Company Evaluation Matrix), End User, and Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-04-29頁數 253報告編號 BT5488

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global collagen & gelatin market is projected to reach USD 1,671.3 million in 2030 from USD 1,295.5 million in 2025, growing at a CAGR of 5.8% during the forecast period. The rising incidence of diabetes, cancer, and cardiovascular diseases increased the demand for efficient treatment, particularly products with advanced wound care. Collagen dressings are becoming popular because they can rapidly heal wounds and minimize infection risk. Moreover, the hike in surgeries has spurred demand for collagen-based biomaterials for sutures, scaffolds, and implants. Additionally, the expanding uses of collagen in tissue engineering and regenerative medicine, specifically in developing bioengineered skin, cartilage, and bone, are creating new avenues for therapeutic use. “The collagen segment held the largest share in the product type market during the forecast period” In 2024, collagen held the largest market within the collagen & gelatin market by product type. The rising adoption of regenerative medicine, orthopedic implants, and dermatological therapies, where native and type-specific collagen plays a critical role in tissue scaffolding and repair. Further, the innovation of recombinant collagen technology and marine-based sources is pushing the boundaries of application into next-generation areas of cell therapy, 3D printing, and custom medicine, thus solidifying it as one of the key material players in the next-generation approach to healthcare solutions. “The hospital end user segment is projected to hold the largest market share during the forecast period” Collagen & gelatin products are mainly consumed by the hospital industry. Hospitals are also the central focal points for healing chronic wounds, burns, diabetes ulcers, and postoperative care, wherein dressings made from collagen find extensive use on account of the well-established efficacy of the product for inducing tissue regrowth and recovery at a faster pace. Moreover, hospitals are always on the edge when using next-generation medical devices, regenerative medicines, orthopedic implants, and drug-delivery systems that heavily utilize collagen-based products. “Asia Pacific is projected to be the fastest-growing region during the forecast period” The Asia Pacific collagen & gelatin market is projected to register the highest growth rate during the forecast period, attributed to the rapidly expanding biopharmaceutical manufacturing capabilities and increasing investment in regenerative medicine and advanced drug delivery systems. China, India, South Korea, and Japan are upscaling their priority in R&D on collagen-based scaffolds, cell therapies, and tissue engineering, driven by substantial financing and academia-industry linkages. Also, an increase in clinical trials and contract manufacturing organizations (CROS and CMOs), which are embracing collagen and gelatin as key substances in drug encapsulation, wound healing formulations, and 3D bioprinting technologies, is another primary driver driving the region’s highest growth over the forecast period. The primary interviews conducted for this report can be categorized as follows: • By Company Type: Tier 1 – 44%, Tier 2 – 32%, and Tier 3 – 24% • By Designation: (Managers) – 45%, (CXOs, Directors) – 30%, and (Executives) –25% • By Region: North America – 40%, Europe – 25%, Asia Pacific – 20%, ROW – 15% Integra LifeSciences Corporation (US), Smith+Nephew plc (UK), DSM-Firmenich (Netherlands), Nitta Gelatin Inc. (Japan), Tessenderlo Group (Belgium), Collplant biotechnologies Ltd (Israel), Collagen Solutions plc (UK), Regenity (US), Medtronic plc (Ireland), and Solventum (US) are some of the key players in the collagen & gelatin market . The study includes an in-depth competitive analysis of these key players in the collagen & gelatin market , with their company profiles, recent developments, and key market strategies. Research Coverage: This report provides a detailed picture of the global collagen & gelatin market. It aims to estimate the size and future growth potential of the market across different segments such as the product type, source, application end user, and region. The report’s scope covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the collagen & gelatin market. Reasons to buy this report : The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall collagen & gelatin market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following pointers: • Analysis of key drivers (growing incidence of diabetes, cancer and chronic diseases, rising demand for advanced wound care products, growing number of surgical procedures, increasing use in tissue engineering and regenerative medicine, and rising application of collagen as drug delivery system), restraints (high manufacturing costs, allergenic & ethical concerns), opportunities (growing adoption of marine & recombinant collagen, expansion of 3D bioprinting for organ and tissue fabrication), and challenges (supply chain vulnerabilities) influencing the growth of the collagen & gelatin market • Product Development/Innovation: Detailed insights into upcoming technologies and new product launches in the collagen & gelatin market • Market Development: Comprehensive information about lucrative markets across varied regions • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the collagen & gelatin market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players in the collagen & gelatin market
目錄 Table of Contents
1 INTRODUCTION 26 1.1 STUDY OBJECTIVES 26 1.2 MARKET DEFINITION 26 1.3 STUDY SCOPE 27 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 27 1.3.2 INCLUSIONS & EXCLUSIONS 28 1.3.3 YEARS CONSIDERED 28 1.3.4 CURRENCY CONSIDERED 29 1.4 STAKEHOLDERS 29 2 RESEARCH METHODOLOGY 30 2.1 RESEARCH DATA 30 2.1.1 SECONDARY DATA 31 2.1.2 PRIMARY DATA 32 2.2 MARKET ESTIMATION METHODOLOGY 33 2.2.1 MARKET ESTIMATION 33 2.2.2 INSIGHTS FROM PRIMARY EXPERTS 35 2.2.3 TOP-DOWN APPROACH 36 2.3 MARKET GROWTH RATE PROJECTION 37 2.4 DATA TRIANGULATION 39 2.5 RESEARCH ASSUMPTIONS 40 2.6 RESEARCH LIMITATIONS 41 2.7 RISK ANALYSIS 41 3 EXECUTIVE SUMMARY 42 4 PREMIUM INSIGHTS 46 4.1 GROWTH OPPORTUNITIES FOR PLAYERS IN COLLAGEN & GELATIN MARKET 46 4.2 COLLAGEN & GELATIN MARKET IN NORTH AMERICA, BY SOURCE AND COUNTRY, 2024 46 4.3 COLLAGEN & GELATIN MARKET SHARE, BY SOURCE, 2025 TO 2030 47 4.4 COLLAGEN & GELATIN MARKET, BY END USER, 2024 47 4.5 COLLAGEN & GELATIN MARKET, BY COUNTRY 48   5 MARKET OVERVIEW 49 5.1 INTRODUCTION 49 5.2 MARKET DYNAMICS 49 5.2.1 DRIVERS 50 5.2.1.1 Growing incidence of diabetes, cancers, and chronic diseases 50 5.2.1.2 Increasing use in tissue engineering and regenerative medicine 51 5.2.1.3 Rising demand for advanced wound care products 51 5.2.1.4 Growing number of surgical procedures 52 5.2.1.5 Surge in use of collagen as drug delivery system 53 5.2.2 RESTRAINTS 53 5.2.2.1 High manufacturing cost 53 5.2.2.2 Allergenic & ethical concerns 54 5.2.3 OPPORTUNITIES 54 5.2.3.1 Growing adoption of marine & recombinant collagen 54 5.2.3.2 Expansion of 3D bioprinting for organ and tissue fabrication 55 5.2.4 CHALLENGES 55 5.2.4.1 Supply chain vulnerabilities 55 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 56 5.4 VALUE CHAIN ANALYSIS 57 5.5 SUPPLY CHAIN ANALYSIS 58 5.6 COLLAGEN & GELATIN MARKET: ECOSYSTEM ANALYSIS 60 5.6.1 PRODUCT PROVIDERS 60 5.6.2 END USERS 61 5.6.3 REGULATORY BODIES 61 5.7 TECHNOLOGY ANALYSIS 62 5.7.1 KEY TECHNOLOGIES 62 5.7.1.1 Extraction technologies 62 5.7.1.2 Hydrolyzation & purification 62 5.7.1.3 Recombinant production 63 5.7.2 COMPLEMENTARY TECHNOLOGIES 63 5.7.2.1 3D scanning & printing 63 5.7.3 ADJACENT TECHNOLOGIES 63 5.7.3.1 Encapsulation 63 5.8 REGULATORY LANDSCAPE 64 5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 5.8.2 REGULATORY FRAMEWORK 66 5.8.2.1 North America 66 5.8.2.2 Europe 67 5.8.2.3 Asia Pacific 67 5.8.2.4 Rest of the World 67   5.9 PORTER’S FIVE FORCES ANALYSIS 68 5.9.1 THREAT OF NEW ENTRANTS 68 5.9.2 THREAT OF SUBSTITUTES 68 5.9.3 BARGAINING POWER OF SUPPLIERS 68 5.9.4 BARGAINING POWER OF BUYERS 69 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 69 5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 69 5.10.1 KEY STAKEHOLDERS 69 5.10.2 BUYING CRITERIA 70 5.11 PATENT ANALYSIS 71 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 75 5.13 PRICING ANALYSIS 76 5.13.1 AVERAGE SELLING PRICE TREND OF COLLAGEN AND GELATIN PRODUCTS, BY KEY PLAYERS, 2023–2024 76 5.13.2 AVERAGE SELLING PRICE TREND OF COLLAGEN AND GELATIN PRODUCTS, BY REGION, 2023–2024 77 5.14 TRADE ANALYSIS 79 5.14.1 IMPORT DATA FOR HS CODE 350300 79 5.14.2 EXPORT DATA HS CODE 350300 80 5.15 IMPACT OF AI/GEN AI ON COLLAGEN & GELATIN MARKET 81 5.16 INVESTMENT AND FUNDING SCENARIO 82 6 COLLAGEN AND GELATIN MARKET, BY PRODUCT TYPE 83 6.1 INTRODUCTION 84 6.2 COLLAGEN 84 6.2.1 GROWING FOCUS ON REGENERATIVE MEDICINE AND DRUG DELIVERY INNOVATION TO BOOST DEMAND 84 6.3 GELATIN 86 6.3.1 RISING FOCUS ON SOFT AND HARD GELATIN CAPSULES IN ORAL DELIVERY TO DRIVE MARKET 86 7 COLLAGEN AND GELATIN MARKET, BY SOURCE 89 7.1 INTRODUCTION 90 7.2 BOVINE SOURCES 91 7.2.1 INCREASED USE IN TISSUE ENGINEERING APPLICATIONS TO DRIVE MARKET 91 7.3 PORCINE SOURCES 94 7.3.1 LOW ALLERGIC RESPONSE AND BIOCOMPATIBILITY OF PORCINE COLLAGEN AND GELATIN TO BOOST DEMAND 94 7.4 OTHER SOURCES 97   8 COLLAGEN MARKET, BY APPLICATION 102 8.1 INTRODUCTION 103 8.2 ORTHOPEDIC 103 8.2.1 INCREASING USE OF COLLAGEN IN ORTHOPEDIC SURGERIES TO DRIVE MARKET 103 8.3 WOUND CARE 105 8.3.1 RISING PREVALENCE OF CHRONIC WOUND CONDITIONS TO BOOST COLLAGEN ADOPTION 105 8.4 DENTAL 108 8.4.1 RISING INCIDENCE OF ORAL DISORDERS TO DRIVE MARKET 108 8.5 SURGICAL 110 8.5.1 INCREASING NUMBER OF SURGICAL PROCEDURES GLOBALLY TO BOOST DEMAND FOR COLLAGEN PRODUCTS 110 8.6 CARDIOVASCULAR 112 8.6.1 GROWING USE OF COLLAGEN PATCHES TO IMPROVE HEART FUNCTION TO SUPPORT MARKET GROWTH 112 8.7 OTHER APPLICATIONS 114 9 GELATIN MARKET, BY APPLICATION 116 9.1 INTRODUCTION 117 9.2 ORTHOPEDIC 117 9.2.1 USE OF GELATIN IN BONE AND CARTILAGE REGENERATION TREATMENT TO DRIVE MARKET 117 9.3 WOUND CARE 119 9.3.1 APPLICATION OF GELATIN-BASED HYDROGELS IN TREATING BURNS TO DRIVE MARKET 119 9.4 OTHER APPLICATIONS 121 10 COLLAGEN AND GELATIN MARKET, BY END USER 123 10.1 INTRODUCTION 124 10.2 HOSPITALS 124 10.2.1 SIGNIFICANT USE OF BIOSURGERY PRODUCTS IN HOSPITALS TO DRIVE MARKET 124 10.3 SURGICAL CENTERS 128 10.3.1 AVAILABILITY OF HIGH-QUALITY AND LOW-COST MEDICAL SERVICES AT SURGICAL CENTERS TO BOOST DEMAND 128   11 COLLAGEN & GELATIN MARKET, BY REGION 132 11.1 INTRODUCTION 133 11.2 NORTH AMERICA 133 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 134 11.2.2 US 138 11.2.2.1 Increasing incidence of periodontitis and burn injuries to drive market 138 11.2.3 CANADA 141 11.2.3.1 Growing geriatric population and volume of surgeries to boost collagen and gelatin demand 141 11.3 EUROPE 144 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 144 11.3.2 GERMANY 148 11.3.2.1 Increase in healthcare expenditure to boost adoption of collagen and gelatin products 148 11.3.3 UK 151 11.3.3.1 High risk of pressure ulcers in diabetic patients to drive market 151 11.3.4 FRANCE 154 11.3.4.1 Well-established healthcare sector to provide lucrative opportunities to collagen and gelatin vendors 154 11.3.5 REST OF EUROPE 156 11.4 ASIA PACIFIC 159 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 160 11.4.2 JAPAN 165 11.4.2.1 Rising elderly population to support market growth 165 11.4.3 CHINA 167 11.4.3.1 Significant elderly population with diabetes to push demand for collagen and gelatin products 167 11.4.4 INDIA 170 11.4.4.1 Increasing healthcare spending by government to stimulate market growth 170 11.4.5 REST OF ASIA PACIFIC 173 11.5 LATIN AMERICA 176 11.5.1 INCREASING NUMBER OF DIABETIC PATIENTS TO RISE DEMAND FOR COLLAGEN AND GELATIN PRODUCTS 176 11.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 177 11.6 MIDDLE EAST & AFRICA 180 11.6.1 GROWING FOCUS ON HEALTHCARE INFRASTRUCTURE IMPROVEMENT TO DRIVE MARKET 180 11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 180   12 COMPETITIVE LANDSCAPE 185 12.1 INTRODUCTION 185 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 185 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN COLLAGEN & GELATIN MARKET 185 12.3 REVENUE ANALYSIS, 2020–2024 187 12.4 MARKET SHARE ANALYSIS, 2024 188 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 190 12.5.1 STARS 190 12.5.2 EMERGING LEADERS 190 12.5.3 PERVASIVE PLAYERS 190 12.5.4 PARTICIPANTS 190 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 192 12.5.5.1 Company footprint 192 12.5.5.2 Region footprint 193 12.5.5.3 Source footprint 194 12.5.5.4 Application footprint 195 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 196 12.6.1 PROGRESSIVE COMPANIES 196 12.6.2 RESPONSIVE COMPANIES 196 12.6.3 DYNAMIC COMPANIES 196 12.6.4 STARTING BLOCKS 196 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 198 12.6.5.1 Detailed list of key startups/SMEs 198 12.6.5.2 Competitive benchmarking of key startups/SMEs 199 12.7 COMPANY VALUATION & FINANCIAL METRICS 200 12.8 BRAND/PRODUCT COMPARISON 201 12.9 COMPETITIVE SCENARIO 202 12.9.1 PRODUCT LAUNCHES 202 12.9.2 DEALS 202 12.9.3 OTHER DEVELOPMENTS 203 13 COMPANY PROFILES 204 13.1 KEY PLAYERS 204 13.1.1 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 204 13.1.1.1 Business overview 204 13.1.1.2 Products offered 205 13.1.1.3 Recent developments 206 13.1.1.3.1 Deals 206 13.1.1.3.2 Other developments 206   13.1.1.4 MnM view 207 13.1.1.4.1 Key strengths 207 13.1.1.4.2 Strategic choices 207 13.1.1.4.3 Weaknesses and competitive threats 207 13.1.2 SMITH+NEPHEW 208 13.1.2.1 Business overview 208 13.1.2.2 Products offered 209 13.1.2.3 MnM view 210 13.1.2.3.1 Key strengths 210 13.1.2.3.2 Strategic choices 210 13.1.2.3.3 Weaknesses and competitive threats 210 13.1.3 DSM-FIRMENICH 211 13.1.3.1 Business overview 211 13.1.3.2 Products offered 212 13.1.3.3 Recent developments 213 13.1.3.3.1 Deals 213 13.1.3.4 MnM view 213 13.1.3.4.1 Key strengths/Right to win 213 13.1.3.4.2 Strategic choices 213 13.1.3.4.3 Weaknesses/Competitive threats 213 13.1.4 NITTA GELATIN INC. 214 13.1.4.1 Business overview 214 13.1.4.2 Products offered 215 13.1.4.3 MnM view 216 13.1.4.3.1 Key strengths 216 13.1.4.3.2 Strategic choices 216 13.1.4.3.3 Weaknesses and competitive threats 216 13.1.5 TESSENDERLO GROUP 217 13.1.5.1 Business overview 217 13.1.5.2 Products offered 218 13.1.5.3 Recent developments 219 13.1.5.3.1 Deals 219 13.1.5.3.2 Other developments 219 13.1.5.4 MnM view 219 13.1.5.4.1 Key strengths/Right to win 219 13.1.5.4.2 Strategic choices 219 13.1.5.4.3 Weaknesses/Competitive threats 219 13.1.6 SOLVENTUM 220 13.1.6.1 Business overview 220 13.1.6.2 Products offered 221 13.1.6.3 Recent developments 222 13.1.6.3.1 Other developments 222 13.1.7 MEDTRONIC PLC 223 13.1.7.1 Business overview 223 13.1.7.2 Products offered 224 13.1.8 COLLPLANT BIOTECHNOLOGIES LTD. 225 13.1.8.1 Business overview 225 13.1.8.2 Products offered 226 13.1.8.3 Recent developments 226 13.1.8.3.1 Product launches 226 13.1.8.3.2 Deals 226 13.1.9 ZIMVIE INC. 227 13.1.9.1 Business overview 227 13.1.9.2 Products offered 228 13.1.10 JELLAGEN 229 13.1.10.1 Business overview 229 13.1.10.2 Products offered 229 13.1.10.3 Recent developments 229 13.1.10.3.1 Other developments 229 13.1.11 COLLAGEN SOLUTIONS PLC 230 13.1.11.1 Business overview 230 13.1.11.2 Products offered 230 13.1.12 REGENITY 231 13.1.12.1 Business overview 231 13.1.12.2 Products offered 231 13.1.12.3 Recent developments 232 13.1.12.3.1 Deals 232 13.1.13 SYMATESE LABS 233 13.1.13.1 Business overview 233 13.1.13.2 Products offered 233 13.1.14 GELITA AG 234 13.1.14.1 Business overview 234 13.1.14.2 Products offered 234 13.2 OTHER PLAYERS 235 13.2.1 BICO 235 13.2.2 MATRICEL GMBH 236 13.2.3 DARLING INGREDIENTS 237 13.2.4 WEISHARDT 238 13.2.5 HYFINE GELATIN CO., LTD. 239 13.2.6 GEISTLICH PHARMA AG 239 13.2.7 SYNERHEAL PHARMACEUTICALS 240 13.2.8 BIOREGEN TECHNOLOGIES 241 13.2.9 MERIL LIFE SCIENCES PVT. LTD. 241 13.2.10 MEDSKIN SUWELACK 242 13.2.11 COLOGENESIS HEALTHCARE PVT LTD 243 13.2.12 DERMARITE INDUSTRIES, LLC 244 13.2.13 EUCARE PHARMACEUTICALS PRIVATE LIMITED 245 14 APPENDIX 246 14.1 DISCUSSION GUIDE 246 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 249 14.3 CUSTOMIZATION OPTIONS 251 14.4 RELATED REPORTS 251 14.5 AUTHOR DETAILS 252
圖表清單 List of Tables & Figures
_ TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 38 TABLE 2 COLLAGEN & GELATIN MARKET: RISK ANALYSIS 41 TABLE 3 COLLAGEN & GELATIN MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 50 TABLE 4 NUMBER OF SURGERIES PERFORMED IN US, 2023–2024 52 TABLE 5 COLLAGEN & GELATIN MARKET: KEY PRODUCT PROVIDERS 60 TABLE 6 COLLAGEN & GELATIN MARKET: KEY END USERS 61 TABLE 7 COLLAGEN & GELATIN MARKET: REGULATORY BODIES 61 TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64 TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65 TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65 TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66 TABLE 12 COLLAGEN & GELATIN MARKET: PORTER’S FIVE FORCES ANALYSIS 68 TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 70 TABLE 14 KEY PATENTS IN GELATIN MARKET, 2022–2024 72 TABLE 15 KEY PATENTS IN COLLAGEN MARKET, 2022–2024 74 TABLE 16 COLLAGEN & GELATIN MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2025–2026 75 TABLE 17 AVERAGE SELLING PRICE TREND OF COLLAGEN AND GELATIN PRODUCTS, BY KEY PLAYERS, 2023–2024 (USD/KG) 77 TABLE 18 BOVINE: AVERAGE SELLING PRICE TREND, BY REGION, 2023–2024 (USD/TON) 78 TABLE 19 PORCINE: AVERAGE SELLING PRICE TREND, BY REGION, 2023–2024 (USD/TON) 78 TABLE 20 POULTRY: AVERAGE SELLING PRICE TREND, BY REGION, 2023–2024 (USD/TON) 78 TABLE 21 MARINE: AVERAGE SELLING PRICE TREND, BY REGION, 2023–2024 (USD/TON) 78 TABLE 22 IMPORT VOLUME FOR HS CODE 350300, 2020–2024 (US DOLLAR THOUSAND) 80 TABLE 23 EXPORT VOLUME FOR HS CODE 854330, 2020–2024 (US DOLLAR THOUSAND) 81 TABLE 24 COLLAGEN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 84 TABLE 25 COLLAGEN MARKET, BY REGION, 2023–2030 (USD MILLION) 85 TABLE 26 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 85 TABLE 27 EUROPE: COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 85 TABLE 28 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 86 TABLE 29 GELATIN MARKET, BY REGION, 2023–2030 (USD MILLION) 87 TABLE 30 NORTH AMERICA: GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 87 TABLE 31 EUROPE: GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 87 TABLE 32 ASIA PACIFIC: GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 88 TABLE 33 COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 90 TABLE 34 GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 90 TABLE 35 BOVINE COLLAGEN MARKET, BY REGION, 2023–2030 (USD MILLION) 91 TABLE 36 NORTH AMERICA: BOVINE COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92 TABLE 37 EUROPE: BOVINE COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92 TABLE 38 ASIA PACIFIC: BOVINE COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92 TABLE 39 BOVINE GELATIN MARKET, BY REGION, 2023–2030 (USD MILLION) 93 TABLE 40 NORTH AMERICA: BOVINE GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 93 TABLE 41 EUROPE: BOVINE GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 93 TABLE 42 ASIA PACIFIC: BOVINE GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 94 TABLE 43 PORCINE COLLAGEN MARKET, BY REGION, 2023–2030 (USD MILLION) 95 TABLE 44 NORTH AMERICA: PORCINE COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 45 EUROPE: PORCINE COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 46 ASIA PACIFIC: PORCINE COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 47 PORCINE GELATIN MARKET, BY REGION, 2023–2030 (USD MILLION) 96 TABLE 48 NORTH AMERICA: PORCINE GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 49 EUROPE: PORCINE GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 50 ASIA PACIFIC: PORCINE GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 51 OTHER COLLAGEN SOURCES MARKET, BY REGION, 2023–2030 (USD MILLION) 98 TABLE 52 NORTH AMERICA: OTHER COLLAGEN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 53 EUROPE: OTHER COLLAGEN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 54 ASIA PACIFIC: OTHER COLLAGEN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 55 OTHER GELATIN SOURCES MARKET, BY REGION, 2023–2030 (USD MILLION) 100 TABLE 56 NORTH AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 57 EUROPE: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 58 ASIA PACIFIC: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 59 COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 103 TABLE 60 COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 104 TABLE 61 NORTH AMERICA: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 62 EUROPE: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 63 ASIA PACIFIC: COLLAGEN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 64 COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 106 TABLE 65 NORTH AMERICA: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 66 EUROPE: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 67 ASIA PACIFIC: COLLAGEN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 68 COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 108 TABLE 69 NORTH AMERICA: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 70 EUROPE: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 71 ASIA PACIFIC: COLLAGEN MARKET FOR DENTAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 72 COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 73 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 74 EUROPE: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 75 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 76 COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 77 NORTH AMERICA: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 78 EUROPE: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 79 ASIA PACIFIC: COLLAGEN MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 80 COLLAGEN MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 81 NORTH AMERICA: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 82 EUROPE: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 83 ASIA PACIFIC: COLLAGEN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 84 GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 117 TABLE 85 GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 86 NORTH AMERICA: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 87 EUROPE: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 88 ASIA PACIFIC: GELATIN MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 89 GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 90 NORTH AMERICA: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 91 EUROPE: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 92 ASIA PACIFIC: GELATIN MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 93 GELATIN MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 94 NORTH AMERICA: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 95 EUROPE: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 96 ASIA PACIFIC: GELATIN MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 97 COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 124 TABLE 98 GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 124 TABLE 99 HOSPITALS: COLLAGEN MARKET, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 100 NORTH AMERICA: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 101 EUROPE: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 102 ASIA PACIFIC: COLLAGEN MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 103 HOSPITALS: GELATIN MARKET, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 104 NORTH AMERICA: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 105 EUROPE: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 106 ASIA PACIFIC: GELATIN MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 107 SURGICAL CENTERS: COLLAGEN MARKET, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 108 NORTH AMERICA: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 109 EUROPE: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 110 ASIA PACIFIC: COLLAGEN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 111 SURGICAL CENTERS: GELATIN MARKET, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 112 NORTH AMERICA: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 113 EUROPE: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 114 ASIA PACIFIC: GELATIN MARKET FOR SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 115 GLOBAL COLLAGEN MARKET, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 116 GLOBAL GELATIN MARKET, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 117 NORTH AMERICA: KEY MACROINDICATORS 134 TABLE 118 NORTH AMERICA: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 135 TABLE 119 NORTH AMERICA: COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 120 NORTH AMERICA: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 136 TABLE 121 NORTH AMERICA: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 136 TABLE 122 NORTH AMERICA: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 137 TABLE 123 NORTH AMERICA: GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 124 NORTH AMERICA: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 137 TABLE 125 NORTH AMERICA: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 138 TABLE 126 NORTH AMERICA: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 138 TABLE 127 US: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 139 TABLE 128 US: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 139 TABLE 129 US: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140 TABLE 130 US: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 140 TABLE 131 US: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 140 TABLE 132 US: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 141 TABLE 133 US: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 141 TABLE 134 CANADA: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 142 TABLE 135 CANADA: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 142 TABLE 136 CANADA: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 143 TABLE 137 CANADA: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 143 TABLE 138 CANADA: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 143 TABLE 139 CANADA: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 144 TABLE 140 CANADA: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 144 TABLE 141 EUROPE: KEY MACROINDICATORS 145 TABLE 142 EUROPE: COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 143 EUROPE: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 146 TABLE 144 EUROPE: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 146 TABLE 145 EUROPE: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 146 TABLE 146 EUROPE: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 147 EUROPE: GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 148 EUROPE: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 147 TABLE 149 EUROPE: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 148 TABLE 150 EUROPE: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 148 TABLE 151 GERMANY: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 149 TABLE 152 GERMANY: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 149 TABLE 153 GERMANY: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 149 TABLE 154 GERMANY: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 150 TABLE 155 GERMANY: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 150 TABLE 156 GERMANY: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 150 TABLE 157 GERMANY: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 151 TABLE 158 UK: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 152 TABLE 159 UK: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 152 TABLE 160 UK: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 152 TABLE 161 UK: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 153 TABLE 162 UK: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 153 TABLE 163 UK: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 153 TABLE 164 UK: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 154 TABLE 165 FRANCE: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 154 TABLE 166 FRANCE: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 155 TABLE 167 FRANCE: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 155 TABLE 168 FRANCE: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 155 TABLE 169 FRANCE: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 156 TABLE 170 FRANCE: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 156 TABLE 171 FRANCE: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 156 TABLE 172 REST OF EUROPE: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 157 TABLE 173 REST OF EUROPE: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 157 TABLE 174 REST OF EUROPE: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 158 TABLE 175 REST OF EUROPE: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 158 TABLE 176 REST OF EUROPE: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 158 TABLE 177 REST OF EUROPE: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 159 TABLE 178 REST OF EUROPE: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 159 TABLE 179 ASIA PACIFIC: KEY MACROINDICATORS 160 TABLE 180 ASIA PACIFIC: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 161 TABLE 181 ASIA PACIFIC: COLLAGEN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 182 ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 162 TABLE 183 ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 163 TABLE 184 ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 185 ASIA PACIFIC: GELATIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 186 ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 164 TABLE 187 ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 164 TABLE 188 ASIA PACIFIC: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 164 TABLE 189 JAPAN: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 165 TABLE 190 JAPAN: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 165 TABLE 191 JAPAN: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 166 TABLE 192 JAPAN: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 166 TABLE 193 JAPAN: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 166 TABLE 194 JAPAN: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 167 TABLE 195 JAPAN: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 167 TABLE 196 CHINA: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 168 TABLE 197 CHINA: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 168 TABLE 198 CHINA: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 168 TABLE 199 CHINA: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 169 TABLE 200 CHINA: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 169 TABLE 201 CHINA: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 169 TABLE 202 CHINA: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 170 TABLE 203 INDIA: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 171 TABLE 204 INDIA: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 171 TABLE 205 INDIA: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 171 TABLE 206 INDIA: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 172 TABLE 207 INDIA: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 172 TABLE 208 INDIA: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 172 TABLE 209 INDIA: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 173 TABLE 210 REST OF ASIA PACIFIC: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 174 TABLE 211 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 174 TABLE 212 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 174 TABLE 213 REST OF ASIA PACIFIC: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 214 REST OF ASIA PACIFIC: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 175 TABLE 215 REST OF ASIA PACIFIC: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 175 TABLE 216 REST OF ASIA PACIFIC: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 176 TABLE 217 LATIN AMERICA: KEY MACROINDICATORS 177 TABLE 218 LATIN AMERICA: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 177 TABLE 219 LATIN AMERICA: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 178 TABLE 220 LATIN AMERICA: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 178 TABLE 221 LATIN AMERICA: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 178 TABLE 222 LATIN AMERICA: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 179 TABLE 223 LATIN AMERICA: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 179 TABLE 224 LATIN AMERICA: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 179 TABLE 225 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 181 TABLE 226 MIDDLE EAST & AFRICA: COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 182 TABLE 227 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 182 TABLE 228 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 182 TABLE 229 MIDDLE EAST & AFRICA: COLLAGEN MARKET, BY END USER, 2023–2030 (USD MILLION) 183 TABLE 230 MIDDLE EAST & AFRICA: GELATIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 183 TABLE 231 MIDDLE EAST & AFRICA: GELATIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 183 TABLE 232 MIDDLE EAST & AFRICA: GELATIN MARKET, BY END USER, 2023–2030 (USD MILLION) 184 TABLE 233 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COLLAGEN AND GELATIN PLAYERS 185 TABLE 234 COLLAGEN & GELATIN MARKET: DEGREE OF COMPETITION 189 TABLE 235 COLLAGEN & GELATIN MARKET: REGION FOOTPRINT 193 TABLE 236 COLLAGEN & GELATIN MARKET: SOURCE FOOTPRINT 194 TABLE 237 COLLAGEN & GELATIN MARKET: APPLICATION FOOTPRINT 195 TABLE 238 COLLAGEN & GELATIN MARKET: DETAILED LIST OF KEY STARTUPS/SMES 198 TABLE 239 COLLAGEN & GELATIN MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 199 TABLE 240 COLLAGEN & GELATIN MARKET: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025 202 TABLE 241 COLLAGEN & GELATIN MARKET: DEALS, JANUARY 2021– MARCH 2025 202 TABLE 242 COLLAGEN & GELATIN MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 203 TABLE 243 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY OVERVIEW 204 TABLE 244 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCTS OFFERED 205 TABLE 245 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: DEALS, JANUARY 2021–MARCH 2025 206 TABLE 246 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 206 TABLE 247 SMITH+NEPHEW: COMPANY OVERVIEW 208 TABLE 248 SMITH+NEPHEW: PRODUCTS OFFERED 209 TABLE 249 DSM-FIRMENICH: COMPANY OVERVIEW 211 TABLE 250 DSM–FIRMENICH: PRODUCTS OFFERED 212 TABLE 251 DSM FIRMENICH: DEALS, JANUARY 2021–MARCH 2025 213 TABLE 252 NITTA GELATIN INC.: COMPANY OVERVIEW 214 TABLE 253 NITTA GELATIN INC.: PRODUCTS OFFERED 215 TABLE 254 TESSENDERLO GROUP: COMPANY OVERVIEW 217 TABLE 255 TESSENDERLO GROUP: PRODUCTS OFFERED 218 TABLE 256 TESSENDERLO GROUP: DEALS, JANUARY 2021–MARCH 2025 219 TABLE 257 TESSENDERLO GROUP: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 219 TABLE 258 SOLVENTUM: COMPANY OVERVIEW 220 TABLE 259 SOLVENTUM: PRODUCTS OFFERED 221 TABLE 260 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 222 TABLE 261 MEDTRONIC PLC: COMPANY OVERVIEW 223 TABLE 262 MEDTRONIC PLC: PRODUCTS OFFERED 224 TABLE 263 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW 225 TABLE 264 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCTS OFFERED 226 TABLE 265 COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025 226 TABLE 266 COLLPLANT BIOTECHNOLOGIES LTD.: DEALS, JANUARY 2021–MARCH 2025 226 TABLE 267 ZIMVIE INC.: COMPANY OVERVIEW 227 TABLE 268 ZIMVIE INC: PRODUCTS OFFERED 228 TABLE 269 JELLAGEN: COMPANY OVERVIEW 229 TABLE 270 JELLAGEN: PRODUCTS OFFERED 229 TABLE 271 JELLAGEN: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 229 TABLE 272 COLLAGEN SOLUTIONS PLC: COMPANY OVERVIEW 230 TABLE 273 COLLAGEN SOLUTIONS PLC: PRODUCTS OFFERED 230 TABLE 274 REGENITY: COMPANY OVERVIEW 231 TABLE 275 REGENITY: PRODUCTS OFFERED 231 TABLE 276 REGENITY: DEALS, JANUARY 2021–MARCH 2025 232 TABLE 277 SYMATESE LABS: COMPANY OVERVIEW 233 TABLE 278 SYMATESE LABS: PRODUCTS OFFERED 233 TABLE 279 GELITA AG: COMPANY OVERVIEW 234 TABLE 280 GELITA AG: PRODUCTS OFFERED 234 _ _ FIGURE 1 COLLAGEN & GELATIN MARKET SEGMENTATION AND REGIONAL SCOPE 27 FIGURE 2 COLLAGEN & GELATIN MARKET: RESEARCH DESIGN 30 FIGURE 3 COLLAGEN & GELATIN MARKET: BREAKDOWN OF PRIMARY INTERVIEWS 32 FIGURE 4 COLLAGEN & GELATIN MARKET: LIST OF PRIMARY PARTICIPANTS 32 FIGURE 5 COLLAGEN & GELATIN MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 33 FIGURE 6 GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024 34 FIGURE 7 ILLUSTRATIVE EXAMPLE OF INTEGRA LIFESCIENCES CORPORATION: REVENUE SHARE ANALYSIS (2024) 34 FIGURE 8 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 35 FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 36 FIGURE 10 COLLAGEN & GELATIN MARKET: CAGR PROJECTIONS 37 FIGURE 11 DATA TRIANGULATION METHODOLOGY 39 FIGURE 12 COLLAGEN & GELATIN MARKET, BY PRODUCT TYPE, 2025 VS. 2030 42 FIGURE 13 COLLAGEN & GELATIN MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION) 43 FIGURE 14 COLLAGEN MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 43 FIGURE 15 GELATIN MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 44 FIGURE 16 COLLAGEN & GELATIN MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 44 FIGURE 17 REGIONAL SNAPSHOT OF COLLAGEN & GELATIN MARKET 45 FIGURE 18 RISING DEMAND FOR ADVANCED WOUND CARE PRODUCTS TO DRIVE MARKET 46 FIGURE 19 BOVINE AND US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN COLLAGEN & GELATIN MARKET 46 FIGURE 20 BOVINE SEGMENT TO DOMINATE MARKET IN 2030 47 FIGURE 21 HOSPITALS SEGMENT HELD LARGER MARKET SHARE IN 2024 47 FIGURE 22 CHINA TO REGISTER SECOND-HIGHEST CAGR IN COLLAGEN MARKET FROM 2025 TO 2030 48 FIGURE 23 INDIA TO EXHIBIT HIGHEST CAGR IN GELATIN MARKET FROM 2025 TO 2030 48 FIGURE 24 COLLAGEN & GELATIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49 FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 56 FIGURE 26 COLLAGEN AND GELATIN VALUE CHAIN 57 FIGURE 27 SUPPLY CHAIN OF COLLAGEN & GELATIN MARKET 59 FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 69 FIGURE 29 KEY BUYING CRITERIA FOR TOP END USERS 70 FIGURE 30 PATENTS GRANTED FOR GELATIN MARKET, JANUARY 2014–DECEMBER 2024 71 FIGURE 31 PATENTS GRANTED FOR COLLAGEN MARKET, JANUARY 2014–DECEMEBER 2024 73 FIGURE 32 AVERAGE SELLING PRICE TREND OF COLLAGEN AND GELATIN PRODUCTS, BY KEY PLAYERS, 2023–2024 (USD/KG) 77 FIGURE 33 AVERAGE SELLING PRICE TREND OF COLLAGEN AND GELATIN PRODUCTS, BY KEY REGION, 2023-2024 (USD/TON) 79 FIGURE 34 COLLAGEN & GELATIN MARKET: IMPACT OF AI 82 FIGURE 35 NORTH AMERICA: COLLAGEN & GELATIN MARKET SNAPSHOT 135 FIGURE 36 ASIA PACIFIC: COLLAGEN & GELATIN MARKET SNAPSHOT 161 FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN COLLAGEN & GELATIN MARKET, 2020–2024 187 FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN COLLAGEN & GELATIN MARKET (2024) 188 FIGURE 39 COLLAGEN & GELATIN MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 191 FIGURE 40 COLLAGEN & GELATIN MARKET: COMPANY FOOTPRINT 192 FIGURE 41 COLLAGEN & GELATIN MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 197 FIGURE 42 COMPANY VALUATION & FINANCIAL METRICS OF KEY VENDORS 200 FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 200 FIGURE 44 COLLAGEN & GELATIN MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 201 FIGURE 45 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT 205 FIGURE 46 SMITH+NEPHEW: COMPANY SNAPSHOT 209 FIGURE 47 DSM-FIRMENICH: COMPANY SNAPSHOT 212 FIGURE 48 NITTA GELATIN INC.: COMPANY SNAPSHOT 215 FIGURE 49 TESSENDERLO GROUP: COMPANY SNAPSHOT 218 FIGURE 50 SOLVENTUM: COMPANY SNAPSHOT 221 FIGURE 51 MEDTRONIC PLC: COMPANY SNAPSHOT 224 FIGURE 52 COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT 225 FIGURE 53 ZIMVIE INC.: COMPANY SNAPSHOT 227

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們